Retatrutide (LY3437943) targets GLP-1, GIP, and glucagon receptors simultaneously, giving it a pharmacological profile distinct from all prior incretin research compounds.
Semaglutide is a GLP-1 receptor agonist with ~94% sequence homology to native GLP-1 and stands among the most studied metabolic research compounds of the past decade.
PT-141 (bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist engaging MC4R through a central mechanism, making it distinct from peripherally-acting compounds.
Oxytocin is a nine-amino acid neuropeptide with established roles in social bonding and trust, with growing research interest in metabolic, cardiac, and pain biology.
Why Site Rotation Matters Injecting the same site repeatedly causes lipodystrophy — hardened, fibrous tissue that absorbs compounds unpredictably. Rotating
Injection Site Reactions Local reactions at the injection site are the most common issue in peptide research protocols. Most trace
Subcutaneous Injection Technique Subcutaneous delivery places the compound in the fatty tissue layer beneath the skin. It is the most
Reconstitution Fundamentals Lyophilized peptides are stable powders until you add solvent. The reconstitution step sets the concentration of every dose
Why Equipment Selection Matters The syringe and needle you choose shape every aspect of injection technique — dosing accuracy, tissue
BPC-157 is a 15-amino acid synthetic pentadecapeptide derived from a protective protein in human gastric juice. This guide covers the current state of preclinical research, proposed mechanisms, and laboratory handling.
